Investor Presentation Cites Examples of Collaborations
The latest presentation (titled "Corporate Presentation-February 2013") shows examples of comparable collaborations on slide 26. Researching each deal from those other biotechs shows these deals bring in hundreds of millions of dollars. There is enormous potential here.
Just as an aside, imgn got approval today for t-dm1 first antibody-drug conjugate approved for a solid tumor indication. I am no expert on these things and only know that we are working with adc's. But I believe this will enhance the value of our portfolio as this continues to be a hot area.